dc.contributor.author | Yılmaz, Ahmet | |
dc.contributor.author | Hanlıoğlu, Selin | |
dc.contributor.author | Demiral, Gökhan | |
dc.contributor.author | Karatepe, Oğuzhan | |
dc.date.accessioned | 2023-12-11T10:04:37Z | |
dc.date.available | 2023-12-11T10:04:37Z | |
dc.date.issued | 2023 | en_US |
dc.identifier.citation | Yılmaz, A., Hanlıoğlu, S., Demiral, G. ve Karatepe, O. (2023). The efficacy of liraglutide combined with intragastric balloon on weight loss. Revista da Associacao Medica Brasileira, 69(12). https://dx.doi.org/10.1590/1806-9282.20230571 | en_US |
dc.identifier.issn | 0104-4230 | |
dc.identifier.issn | 1806-9282 | |
dc.identifier.uri | https://dx.doi.org/10.1590/1806-9282.20230571 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/11976 | |
dc.description.abstract | OBJECTIVE: Intragastric balloon placement is an effective method for weight reduction. The aim of this study was to evaluate the efficacy of combining liraglutide with intragastric balloon.METHODS: Initially, demographic data of patients such as age, gender, comorbid diseases, adverse events, initial weight, height, body mass index,percent body fat, and waist-hip ratio were collected. Weight, body mass index, percent body fat, and waist-hip ratio were measured in the second, third, fourth, fifth, and sixth months. Then, intragastric balloon was removed and liraglutide was stopped.RESULTS: A total of 50 patients were included in the study, of whom 28 (56%) were in Group A (intragastric balloon) and 22 (44%) were in Group B (plus liraglutide). Weight change at the time of balloon removal was higher in Group B [median weight change 13.8 (7.8 min to 16.8 max) versus 7.9 (4.8 min to 11.8 max); p<0.01]. When the weight, percent body fat, body mass index, and waist-hip ratio changes were compared according to gender, no significant difference was observed in the groups. Comorbid diseases were hypertension in 7 patients (4 in Group A and 3 in Group B) and diabetes in 9 patients (5 in Group A and 4 in Group B). No statistical significance was found.CONCLUSION: Liraglutide has benefits in terms of weight, percent body fat, and body mass index reduction when administered with intragastric balloon. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Associacao Medica Brasileira | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Glucagon-Like Peptide 1 | en_US |
dc.subject | Gastric Balloon | en_US |
dc.subject | Liraglutide | en_US |
dc.subject | Obesity | en_US |
dc.subject | Body Weight Changes | en_US |
dc.title | The efficacy of liraglutide combined with intragastric balloon on weight loss | en_US |
dc.type | article | en_US |
dc.relation.ispartof | Revista da Associacao Medica Brasileira | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Genel Cerrahi Ana Bilim Dalı | en_US |
dc.authorid | 0000-0002-1393-5484 | en_US |
dc.identifier.volume | 69 | en_US |
dc.identifier.issue | 12 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.doi | 10.1590/1806-9282.20230571 | en_US |
dc.institutionauthor | Yılmaz, Ahmet | |
dc.identifier.wosquality | Q4 | en_US |
dc.identifier.wos | 001107321500001 | en_US |
dc.identifier.scopus | 2-s2.0-85177991960 | en_US |
dc.identifier.pmid | 37971120 | en_US |
dc.identifier.scopusquality | Q3 | en_US |